Ulla Wändel Liminga, the newly elected chair of the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC), will be overseeing a number of activities in the committee’s 2024 work plan as she assumes her role in September.
There are nearly three dozen activities listed in the PRAC’s 2024 work plan, a number of which are yet...



